{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:07:26Z","timestamp":1791493646618,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Joint Funds for the Innovation of Science and Technology,Fujian Province","award":["No.2023Y9071"],"award-info":[{"award-number":["No.2023Y9071"]}]},{"name":"the Fujian Provincial Health Technology Project","award":["No.2021CXB006"],"award-info":[{"award-number":["No.2021CXB006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93081-7","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T01:39:05Z","timestamp":1742261945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["ITGB5 is a prognostic factor in colorectal cancer and promotes cancer progression and metastasis through the Wnt signaling pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhihua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"93081_CR1","doi-asserted-by":"publisher","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73 (1), 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","DOI":"10.3322\/caac.21763"},{"issue":"3","key":"93081_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"93081_CR3","doi-asserted-by":"publisher","unstructured":"GBD 2019 Colorectal Cancer Collaborators. Global, regional, and National burden of colorectal cancer and its risk factors, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol. Hepatol. 7 (7), 627\u2013647. https:\/\/doi.org\/10.1016\/S2468-1253(22)00044-9 (2022). Erratum in: Lancet Gastroenterol Hepatol. 2022;7(8):704.","DOI":"10.1016\/S2468-1253(22)00044-9"},{"issue":"5","key":"93081_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia, C. et al. Cancer statistics in China and united States, 2022: profiles, trends, and determinants. Chin. Med. J. (Engl). 135 (5), 584\u2013590. https:\/\/doi.org\/10.1097\/CM9.0000000000002108 (2022).","journal-title":"Chin. Med. J. (Engl)"},{"issue":"10125","key":"93081_CR5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani, C. et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet (London England) 391 (10125), 1023\u20131075. https:\/\/doi.org\/10.1016\/s0140-6736(17)33326-3 (2018).","journal-title":"Lancet (London England)"},{"issue":"1","key":"93081_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes, A. et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann. Oncol. 34 (1), 10\u201332. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.003 (2023).","journal-title":"Ann. Oncol."},{"issue":"4","key":"93081_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.23922\/jarc.2022-048","volume":"6","author":"EJ Park","year":"2022","unstructured":"Park, E. J. & Baik, S. H. Recent advance in the surgical treatment of metastatic colorectal cancer\u2014An english version. J. Anus Rectum Colon. 6 (4), 213\u2013220. https:\/\/doi.org\/10.23922\/jarc.2022-048 (2022).","journal-title":"J. Anus Rectum Colon"},{"key":"93081_CR8","doi-asserted-by":"publisher","unstructured":"Su, C. Y. et al. Integrin structure, activation, and interactions. Cold Spring. Harb. Perspect. Biol. 3 (3). https:\/\/doi.org\/10.1101\/cshperspect.a004994 (2011).","DOI":"10.1101\/cshperspect.a004994"},{"issue":"3","key":"93081_CR9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/brv.12398","volume":"93","author":"B Nieuwenhuis","year":"2018","unstructured":"Nieuwenhuis, B., Haenzi, B., Andrews, M. R., Verhaagen, J. & Fawcett, J. W. Integrins promote axonal regeneration after injury of the nervous system. Biol. Rev. Camb. Philos. Soc. 93 (3), 1339\u20131362. https:\/\/doi.org\/10.1111\/brv.12398 (2018).","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"issue":"1","key":"93081_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13046-018-0763-x","volume":"37","author":"R Huang","year":"2018","unstructured":"Huang, R. & Rofstad, E. K. Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma. J. Exp. Clin. Cancer Res. 37 (1), 92. https:\/\/doi.org\/10.1186\/s13046-018-0763-x (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"93081_CR11","doi-asserted-by":"publisher","first-page":"579068","DOI":"10.3389\/fphar.2020.579068","volume":"11","author":"QR Guo","year":"2020","unstructured":"Guo, Q. R., Li, J. J., Liu, Y., Yan, Y. Y. & Zhang, J. Y. The biological functions and clinical applications of integrins in cancers. Front. Pharmacol. 11, 579068. https:\/\/doi.org\/10.3389\/fphar.2020.579068 (2020).","journal-title":"Front. Pharmacol."},{"issue":"9","key":"93081_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi, H. & Ivaska, J. Every step of the way: integrins in cancer progression and metastasis. Nat. Rev. Cancer 18 (9), 533\u2013548. https:\/\/doi.org\/10.1038\/s41568-018-0038-z (2018).","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"93081_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/ijd.14850","volume":"59","author":"SM Arias-Mejias","year":"2020","unstructured":"Arias-Mejias, S. M. et al. The role of integrins in melanoma: a review. Int. J. Dermatol. 59 (5), 525\u2013534. https:\/\/doi.org\/10.1111\/ijd.14850 (2020).","journal-title":"Int. J. Dermatol."},{"key":"93081_CR14","doi-asserted-by":"publisher","first-page":"816230","DOI":"10.3389\/fcell.2021.816230","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu, D., Liu, S., Fang, Y., Liu, L. & Hu, K. Comprehensive analysis of the expression and prognosis for ITGBs: identification of ITGB5 as a biomarker of poor prognosis and correlated with immune infiltrates in gastric cancer. Front. Cell. Dev. Biol. 9, 816230. https:\/\/doi.org\/10.3389\/fcell.2021.816230 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"key":"93081_CR15","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3389\/fonc.2019.00904","volume":"9","author":"LY Zhang","year":"2019","unstructured":"Zhang, L. Y. et al. Integrin beta 5 is a prognostic biomarker and potential therapeutic target in glioblastoma. Front. Oncol. 9, 904. https:\/\/doi.org\/10.3389\/fonc.2019.00904 (2019).","journal-title":"Front. Oncol."},{"key":"93081_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001050","author":"W Shi","year":"2021","unstructured":"Shi, W. et al. Integrin beta5 enhances the malignancy of human colorectal cancer by increasing the TGF-beta signaling. Anticancer Drugs https:\/\/doi.org\/10.1097\/CAD.0000000000001050 (2021).","journal-title":"Anticancer Drugs"},{"issue":"6","key":"93081_CR17","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41401-021-00757-7","volume":"43","author":"YQ Chen","year":"2022","unstructured":"Chen, Y. Q. et al. Osthole inhibits the migration and invasion of highly metastatic breast cancer cells by suppressing ITG\u03b13\/ITG\u03b25 signaling. Acta Pharmacol. Sin. 43 (6), 1544\u20131555. https:\/\/doi.org\/10.1038\/s41401-021-00757-7 (2022).","journal-title":"Acta Pharmacol. Sin"},{"issue":"25","key":"93081_CR18","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1038\/onc.2012.320","volume":"32","author":"A Bianchi-Smiraglia","year":"2013","unstructured":"Bianchi-Smiraglia, A., Paesante, S. & Bakin, A. V. Integrin beta5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene 32 (25), 3049\u20133058. https:\/\/doi.org\/10.1038\/onc.2012.320 (2013).","journal-title":"Oncogene"},{"key":"93081_CR19","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"93081_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"93081_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGFbeta attenuates tumour response to PD-L1 Blockade by contributing to exclusion of T cells. Nature 554, 544\u2013548 (2018).","journal-title":"Nature"},{"key":"93081_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","volume":"17","author":"Y Senbabaoglu","year":"2016","unstructured":"Senbabaoglu, Y. et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 17, 231 (2016).","journal-title":"Genome Biol."},{"key":"93081_CR23","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg, J. E. et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet 387, 1909\u20131920 (2016).","journal-title":"Lancet"},{"issue":"5","key":"93081_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","volume":"7","author":"D Zeng","year":"2019","unstructured":"Zeng, D. et al. Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures. Cancer Immunol. Res. 7 (5), 737\u2013750 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"93081_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"93081_CR26","doi-asserted-by":"publisher","first-page":"816230","DOI":"10.3389\/fcell.2021.816230","volume":"9","author":"D Liu","year":"2021","unstructured":"Liu, D. et al. Comprehensive analysis of the expression and prognosis for ITGBs: identification of ITGB5 as a biomarker of poor prognosis and correlated with immune infiltrates in gastric cancer. Front. Cell. Dev. Biol. 9, 816230 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"93081_CR27","doi-asserted-by":"publisher","first-page":"eabl7895","DOI":"10.1126\/scitranslmed.abl7895","volume":"15","author":"L Su","year":"2023","unstructured":"Su, L. et al. Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models. Sci. Transl. Med. 15, eabl7895 (2023).","journal-title":"Sci. Transl. Med."},{"key":"93081_CR28","doi-asserted-by":"publisher","first-page":"145990","DOI":"10.1016\/j.gene.2021.145990","volume":"808","author":"J Yu","year":"2022","unstructured":"Yu, J., Yang, K., Zheng, J., Sun, X. & Zhao, W. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma. Gene 808, 145990. https:\/\/doi.org\/10.1016\/j.gene.2021.145990 (2022).","journal-title":"Gene"},{"issue":"6","key":"93081_CR29","doi-asserted-by":"publisher","first-page":"101042831770788","DOI":"10.1177\/1010428317707881","volume":"39","author":"Q Zhao","year":"2017","unstructured":"Zhao, Q. et al. MFG-E8 overexpression promotes colorectal cancer progression via AKT\/MMPs signalling. Tumour Biol. 39 (6), 1010428317707881. https:\/\/doi.org\/10.1177\/1010428317707881 (2017).","journal-title":"Tumour Biol."},{"key":"93081_CR30","doi-asserted-by":"publisher","first-page":"130043","DOI":"10.1016\/j.ijbiomac.2024.130043","volume":"262","author":"L Zong","year":"2024","unstructured":"Zong, L. et al. A review of matrix metalloproteinase-2-sensitive nanoparticles as a novel drug delivery for tumor therapy. Int. J. Biol. Macromol. 262, 130043 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"93081_CR31","first-page":"5934","volume":"13","author":"B Tan","year":"2023","unstructured":"Tan, B. et al. MMP11 and MMP14 contribute to the interaction between castration-resistant prostate cancer and adipocytes. Am. J. Cancer Res. 13, 5934\u20135949 (2023).","journal-title":"Am. J. Cancer Res."},{"key":"93081_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00018-023-05077-z","volume":"81","author":"W Liu","year":"2024","unstructured":"Liu, W. et al. WNT5A regulates the proliferation, apoptosis and stemness of human stem Leydig cells via the \u03b2-catenin signaling pathway. Cell. Mol. Life Sci. 81, 93 (2024).","journal-title":"Cell. Mol. Life Sci."},{"key":"93081_CR33","doi-asserted-by":"crossref","unstructured":"Nie, R. et al. WIF1 regulation of follicular development in chickens: modulates granulosa cell proliferation and progesterone synthesis via Wnt\/\u03b2-catenin signaling pathway. Int. J. Mol. Sci. 25 (2024).","DOI":"10.3390\/ijms25031788"},{"issue":"1","key":"93081_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol. Cancer 21 (1), 144. https:\/\/doi.org\/10.1186\/s12943-022-01616-7 (2022).","journal-title":"Mol. Cancer"},{"key":"93081_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","volume":"41","author":"S Dong","year":"2022","unstructured":"Dong, S. et al. ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer. J. Exp. Clin. Cancer Res. 41, 15 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"93081_CR36","doi-asserted-by":"crossref","unstructured":"Xu, T. et al. Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer. Cell. Death Differ. (2024).","DOI":"10.1038\/s41418-024-01267-9"},{"key":"93081_CR37","doi-asserted-by":"crossref","unstructured":"Liu, X. et al. HIF-1-regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt\/\u03b2-catenin pathway activation. Proc. Natl. Acad. Sci. USA 118 (2021).","DOI":"10.1073\/pnas.2109144118"},{"key":"93081_CR38","doi-asserted-by":"publisher","first-page":"16872","DOI":"10.1073\/pnas.1902843116","volume":"116","author":"R Hern\u00e1ndez-Mart\u00ednez","year":"2019","unstructured":"Hern\u00e1ndez-Mart\u00ednez, R., Ramkumar, N. & Anderson, K. V. p120-catenin regulates WNT signaling and EMT in the mouse embryo. Proc. Natl. Acad. Sci. U S A 116, 16872\u201316881 (2019).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"93081_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41419-024-06468-1","volume":"15","author":"K Lin","year":"2024","unstructured":"Lin, K. et al. Collagen I-induced VCAN\/ERK signaling and PARP1\/ZEB1-mediated metastasis facilitate OSBPL2 defect to promote colorectal cancer progression. Cell. Death Dis. 15, 85 (2024).","journal-title":"Cell. Death Dis."},{"key":"93081_CR40","doi-asserted-by":"publisher","first-page":"eade3422","DOI":"10.1126\/sciadv.ade3422","volume":"9","author":"P-L Hsu","year":"2023","unstructured":"Hsu, P-L. et al. Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis. Sci. Adv. 9, eade3422 (2023).","journal-title":"Sci. Adv."},{"key":"93081_CR41","doi-asserted-by":"publisher","first-page":"113796","DOI":"10.1016\/j.celrep.2024.113796","volume":"43","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Suppression of the METTL3-mA-integrin \u03921 axis by extracellular acidification impairs T cell infiltration and antitumor activity. Cell. Rep. 43, 113796 (2024).","journal-title":"Cell. Rep."},{"key":"93081_CR42","doi-asserted-by":"publisher","first-page":"1320614","DOI":"10.3389\/fimmu.2023.1320614","volume":"14","author":"M Carretta","year":"2023","unstructured":"Carretta, M. et al. Dissecting tumor microenvironment heterogeneity in syngeneic mouse models: insights on cancer-associated fibroblast phenotypes shaped by infiltrating T cells. Front. Immunol. 14, 1320614 (2023).","journal-title":"Front. Immunol."},{"key":"93081_CR43","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3389\/fimmu.2020.01052","volume":"11","author":"L Guo","year":"2020","unstructured":"Guo, L., Wang, C., Qiu, X., Pu, X. & Chang, P. Colorectal cancer immune infiltrates: significance in patient prognosis and immunotherapeutic efficacy. Front. Immunol. 11, 1052. https:\/\/doi.org\/10.3389\/fimmu.2020.01052 (2020).","journal-title":"Front. Immunol."},{"issue":"2","key":"93081_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3748\/wjg.v25.i2.151","volume":"25","author":"CV De Almeida","year":"2019","unstructured":"De Almeida, C. V., de Camargo, M. R., Russo, E. & Amedei, A. Role of diet and gut microbiota on colorectal cancer Immunomodulation. World J. Gastroenterol. 25 (2), 151\u2013162. https:\/\/doi.org\/10.3748\/wjg.v25.i2.151 (2019).","journal-title":"World J. Gastroenterol."},{"key":"93081_CR45","doi-asserted-by":"publisher","unstructured":"Mola, S., Pandolfo, C., Sica, A. & Porta, C. The macrophages-microbiota interplay in colorectal cancer (CRC)-related inflammation: prognostic and therapeutic significance. Int. J. Mol. Sci. 21 (18). https:\/\/doi.org\/10.3390\/ijms21186866 (2020).","DOI":"10.3390\/ijms21186866"},{"issue":"19","key":"93081_CR46","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.3390\/cancers14194755","volume":"14","author":"W Zheng","year":"2022","unstructured":"Zheng, W. et al. Tumor-associated neutrophils in colorectal cancer development, progression and immunotherapy. Cancers (Basel) 14 (19), 4755. https:\/\/doi.org\/10.3390\/cancers14194755 (2022).","journal-title":"Cancers (Basel)"},{"issue":"16","key":"93081_CR47","doi-asserted-by":"publisher","first-page":"8470","DOI":"10.3390\/ijms22168470","volume":"22","author":"H Wang","year":"2021","unstructured":"Wang, H., Tian, T. & Zhang, J. Tumor-associated macrophages (TAMs) in colorectal cancer (CRC): from mechanism to therapy and prognosis. Int. J. Mol. Sci. 22 (16), 8470. https:\/\/doi.org\/10.3390\/ijms22168470 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"93081_CR48","doi-asserted-by":"crossref","unstructured":"Zhu, X. et al. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer. J. Immunother. Cancer 10 (2022).","DOI":"10.1136\/jitc-2021-004219"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93081-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T13:21:32Z","timestamp":1742304092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93081-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93081"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93081-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study project was approved by the Ethics Committee of the First Affiliated Hospital of Fujian Medical University (Approval Nos. MRCTA and ECFAH of FMU [2019]021). The Ethics Committee of the First Affiliated Hospital of Fujian Medical University approved the study protocol. All procedures involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants involved in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"9225"}}